AP2001002245A0 - Regulation of anesthesia. - Google Patents

Regulation of anesthesia.

Info

Publication number
AP2001002245A0
AP2001002245A0 APAP/P/2001/002245A AP2001002245A AP2001002245A0 AP 2001002245 A0 AP2001002245 A0 AP 2001002245A0 AP 2001002245 A AP2001002245 A AP 2001002245A AP 2001002245 A0 AP2001002245 A0 AP 2001002245A0
Authority
AP
ARIPO
Prior art keywords
subject
anesthesia
regulation
delta
inducing peptide
Prior art date
Application number
APAP/P/2001/002245A
Other languages
English (en)
Inventor
Christopher John Douglas Pomfret
Michael Alkire
Richard Haier
Jim Fallon
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9902469.7A external-priority patent/GB9902469D0/en
Application filed by Univ Manchester filed Critical Univ Manchester
Publication of AP2001002245A0 publication Critical patent/AP2001002245A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/2001/002245A 1999-02-05 2000-02-01 Regulation of anesthesia. AP2001002245A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9902469.7A GB9902469D0 (en) 1999-02-05 1999-02-05 Brain metabolism
US12032699P 1999-02-17 1999-02-17
US15566199P 1999-09-24 1999-09-24
PCT/GB2000/000281 WO2000045832A2 (en) 1999-02-05 2000-02-01 Regulation of anaesthesia

Publications (1)

Publication Number Publication Date
AP2001002245A0 true AP2001002245A0 (en) 2001-09-30

Family

ID=27269636

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002245A AP2001002245A0 (en) 1999-02-05 2000-02-01 Regulation of anesthesia.

Country Status (15)

Country Link
EP (1) EP1148887A2 (zh)
JP (1) JP2002536337A (zh)
KR (1) KR20010101992A (zh)
CN (1) CN1346278A (zh)
AP (1) AP2001002245A0 (zh)
AU (1) AU2445900A (zh)
BR (1) BR0008046A (zh)
CA (1) CA2360124A1 (zh)
ID (1) ID30518A (zh)
IL (1) IL144572A0 (zh)
MX (1) MXPA01007949A (zh)
NO (1) NO20013795L (zh)
OA (1) OA11758A (zh)
TR (1) TR200102265T2 (zh)
WO (1) WO2000045832A2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1275308A1 (en) * 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals
US20100210540A1 (en) * 2007-09-11 2010-08-19 Dorian Bevec Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent
GB201116271D0 (en) * 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
CN108376559B (zh) * 2018-02-28 2020-10-16 复旦大学附属中山医院 乙醛脱氢酶2基因型在麻醉剂量计算中的应用
CN112535727A (zh) * 2020-12-24 2021-03-23 安域生物制药(杭州)有限公司 一种具有睡眠改善作用的短肽凝胶及其制备方法
CN112908454B (zh) * 2021-02-26 2023-08-29 西安交通大学口腔医院 一种智能保管麻醉剂的方法及系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634331A5 (de) * 1977-06-30 1983-01-31 Hoffmann La Roche Phosphorylierte nonapeptide und verfahren zu deren herstellung.
CA1188989A (en) * 1981-05-21 1985-06-18 Richard R. Scherschlicht Nonapeptide for the treatment of drug withdrawal symptoms
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
RU2104717C1 (ru) * 1995-07-07 1998-02-20 Новокузнецкий государственный институт усовершенствования врачей Способ анестезии при операциях у больных с синдромом лериша

Also Published As

Publication number Publication date
AU2445900A (en) 2000-08-25
ID30518A (id) 2001-12-13
OA11758A (en) 2005-07-19
WO2000045832A3 (en) 2000-11-30
BR0008046A (pt) 2001-11-06
WO2000045832A2 (en) 2000-08-10
CA2360124A1 (en) 2000-08-10
NO20013795D0 (no) 2001-08-02
JP2002536337A (ja) 2002-10-29
CN1346278A (zh) 2002-04-24
IL144572A0 (en) 2002-05-23
TR200102265T2 (tr) 2001-12-21
MXPA01007949A (es) 2003-06-04
KR20010101992A (ko) 2001-11-15
EP1148887A2 (en) 2001-10-31
NO20013795L (no) 2001-08-02

Similar Documents

Publication Publication Date Title
WO2001085664A3 (en) Compounds and methods for regulating bacterial growth and pathogenesis
EP1015039A4 (en) MEANS OF OXYGEN DELIVERY AND THEIR APPLICATION
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
ATE394082T1 (de) Vorrichtung zur verbindung von wirbeln der wirbelsäule
HK1049501A1 (en) Functional genomics using zinc finger proteins
WO2003002717A3 (en) Biological activity of ak155
UA84432C2 (ru) Очищенные пептиды и соединения, которые их содержат
BG104780A (en) Inhibitors of phospholipase enzymes
PT1671949E (pt) Piridinilaminas substituídas
MY129015A (en) Process for coating stents and other medical devices using super-critical carbon dioxide
ZA948926B (en) Non-peptide tachykinin recptor antagonists
ATE466582T1 (de) 16-phenoxy-lipoxin analoge zur medizinischen verwendung
WO1999025817A3 (en) Tc1-based transposon vectors
AP2001002245A0 (en) Regulation of anesthesia.
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
ATE311802T1 (de) Gargerät
WO2002066045A3 (en) Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a
EP1313753A4 (en) REGULATOR GENES AND USEABLE SYSTEM FOR THE DIAGNOSIS AND THERAPY OF THE OSTEOPOROSIS
MY112148A (en) Suspension concentrate compositions of arylpyrrole insecticidal and acarricidal agents
DE69724062D1 (de) Benzothiophenderivate, Zwischenprodukte, Verfahren, Zubereitungen und Methoden
WO2001012838A3 (en) Compounds which modulate the activity of an lpa receptor
MXPA01003246A (es) Receptor para factor oostatico de modulacion de trispsina y uso del mismo.
GB0115382D0 (en) Mutant
GB2344107A (en) Gene
DE69723639D1 (de) Benzothiophenverbindungen, Zubereitungen und Verfahren